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The majority of patients with schizophrenia display neurocognitive deficits (e.g.,
memory impairment) as well as inflated cognitive biases (e.g., jumping to conclusions).
Both cognitive domains are implicated in the pathogenesis of the disorder and are
known to compromise functional outcome. At present, there is a dearth of effective
treatment options. A total of 90 patients with schizophrenia were recruited online
(a diagnosis of schizophrenia had been confirmed in a large subgroup during a
previous hospital admission). Subsequent to a baseline assessment encompassing
psychopathology, self-reported cognition as well as objective memory and reasoning
tests, patients were randomized to one of three conditions: standard cognitive
remediation (mybraintraining), metacognition-augmented cognition remediation (CR)
condition (variant of mybraintraining which encouraged patients to reduce speed of
decision-making and attenuate response confidence when participants made high-
confidence judgements and hasty incorrect decisions) and a waitlist control group.
Patients were retested after 6 weeks and again 3 months after the second assessment.
Groups did not differ on psychopathology and neurocognitive parameters at any
timepoint. However, at follow-up the metacognitive-augmented CR group displayed
a significant reduction on jumping to conclusions and overconfidence. Treatment
adherence correlated with a reduction of depression; gains in the training exercises
from the standard mybraintraining condition were correlated with improved objective
memory performance. The study suggests that metacognition-augmented CR may
ameliorate cognitive biases but not neurocognition. The study ties in well with prior
research showing that neurocognitive dysfunctions are rather resistant to change; the
failure to detect significant improvement of CR or metacognition-augmented CR on
psychopathology and neurocognition over time may partly be attributed to a number
of methodological limitations of our study (low psychopathology and chronicity of
participants, low “dosage,” narrow range of tests, self-report psychopathology scales).
Keywords: psychosis, schizophrenia, neurocognition, cognitive biases, cognitive remediation
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Introduction
Schizophrenia is frequently accompanied by neuropsychological
deﬁcits which are spread across a wide range of cognitive
functions (Heinrichs and Zakzanis, 1998; Keefe and Harvey,
2012). Memory and attention problems in concert with social
cognitive impairments (Fett et al., 2011) are a major predictor
for disability and low functional outcome in the disorder (Green,
1996; Green et al., 2004; Lepage et al., 2014). Neurocognitive
deﬁcits are also a risk factor for poor symptomatic outcome.
First, memory problems aggravate medication non-adherence
as patients may fail to remember the rationale for drug
administration or forget to take their medication (Moritz
et al., 2013b), particularly due to prospective memory failure
(Moritz et al., 2004). In addition, compromised attention,
reasoning, and memory capacity may limit the comprehension
and internalization of knowledge and skills acquired during
cognitive therapy and thus impede transfer to everyday life.
The causes underlying neurocognitive deﬁcits in
schizophrenia are multi-facetted. Apart from early
(neurodevelopmental) deﬁcits that already manifest prior
to the onset of the disorder (Bang et al., 2014; Corigliano et al.,
2014), avolition/lack of eﬀort and a restricted non-challenging
environment/hospitalization may compromise cognition.
Some recent studies suggest that (conventional) antipsychotics
impair brain functioning (Ukai et al., 2004; Ho et al., 2011;
Gasso et al., 2012), which in turn hampers neurocognition.
While antipsychotic-induced cognitive deﬁcits are clearly
non-desired and thus usually considered a side-eﬀect, there is
emerging, albeit not yet conclusive, evidence that such secondary
cognitive deﬁcits may in fact be one mechanism through which
antipsychotics reduce positive symptoms (“eﬀect by defect”
hypothesis; Moritz et al., 2013a). In other words, there may
be two sides of the same coin: doubt and reduced speed of
information processing induced by antipsychotics may be a
prerequisite for the dissolution of delusions.
Currently, there is a dearth of potent treatment options against
cognitive deﬁcits. Early claims that atypical neuroleptics may
act as cognitive enhancers have not lived up to its expectations
(Keefe et al., 2007; Davidson et al., 2009; Keefe and Harvey,
2012). Atypical neuroleptics leave cognition uncompromised at
best. It should also be taken into account that side eﬀects such as
extrapyramidal symptoms (Fervaha et al., 2015) and concomitant
medication, particularly anticholinergic drugs (Vinogradov et al.,
2009) and tranquilizers/benzodiazepines (Deckersbach et al.,
2011) are known to aggravate neurocognitive deﬁcits, too.
Cognitive remediation (CR) has shown some promise; meta-
analyses indicate that CR exerts a (small-to-moderate) eﬀect
on neurocognition (McGurk et al., 2007; Wykes et al., 2011)
but does not have a lasting impact on symptomatology (Wykes
et al., 2011). However, this promising evidence has to be weighed
against the eﬀort that needs to be invested to produce those
changes (e.g., one-on-one training, tailored material). Recently,
low-threshold group CR trainings have shown some beneﬁcial
eﬀect. A meta-analysis on 36 studies reveals that Integrated
Psychological Therapy (IPT), a program at the interface of
neurocognition and social cognition, exerts signiﬁcant positive
eﬀects relative to control interventions on neurocognition, social
cognition, psychosocial functioning, and negative symptoms
(Roder et al., 2011). In a recent study we were able to show
that a CR group improved attention after 3 years relative to a
metacognition group (Moritz et al., 2014c).
Apart from “cold” cognitive deﬁcits mirroring brain
dysfunction in psychosis, particularly in the frontal and temporal
lobes, there is an emerging interest in cognitive biases. Cognitive
biases are not deﬁcits per se but represent alterations or styles
in the perception and processing of information, for example a
preference to remember positive versus negative information.
Cognitive biases are not pathological as such; some cognitive
biases can even promote psychological well-being (e.g., self-
serving bias, “Pollyanna eﬀect”; Bentall, 1992; Pohl, 2004).
Among other cognitive distortions, studies have implicated
jumping to conclusions (Garety et al., 1991) and overconﬁdence
in errors (Moritz et al., 2003) in the formation and maintenance
of psychosis. To summarize, a plethora of studies suggest that
patients with schizophrenia are hastier in gathering information
(for reviews, see Garety and Freeman, 1999, 2013; Fine et al.,
2007) and are more conﬁdent in erroneous responses pertaining
to memory (Moritz and Woodward, 2006a; Gaweda et al., 2012;
Peters et al., 2013) and social cognition (Kother et al., 2012;
Moritz et al., 2012b) relative to non-clinical and psychiatric
controls. Recent evidence suggests that this extends to perception
(Moritz et al., 2014b). Both biases foster the formation of
momentous false decisions that under some contextual factors
may promote delusions (Moritz and Woodward, 2006b; Garety
and Freeman, 2013). To illustrate, jumping to conclusions may
lead a person with a history of psychosis to infer that a friend
who is not calling back within 2 days has turned his back on him
and is not trustworthy anymore. This along with overconﬁdence
in errors may later turn the initial benign suspicion into a
serious false belief (e.g., that the friend is a police spy who has
gathered suﬃcient information against the patient so that they
can terminate surveillance). Once such ideas have systematized,
judgments are usually not validated or questioned anymore and
the person is no longer open to disconﬁrmatory evidence, the
latter representing another prominent cognitive bias (Woodward
et al., 2006, 2008; Veckenstedt et al., 2011).
The present study examined the eﬃcacy of CR training
versus a CR training combined with a bias modiﬁcation
approach. To this end, a low-threshold online CR training called
mybraintraining Professional (from here on “mybraintraining”)
was administered. Mybraintraining intends to improve
neurocognitive functioning by training four major faculties:
calculation, logic, memory, and vision. We set up two
experimental CR conditions which were tested against a
waitlist control group. In the standard CR condition, patients
were encouraged to avoid making errors when performing
cognitive tasks that were presented under time restriction. In the
metacognition-augmented CR condition the same exercises were
presented but patients additionally had to rate their responses
in terms of conﬁdence, that is, whether they were certain or not
that their responses were correct. Whenever a subject made a
high-conﬁdent error and/or an error committed with very short
reaction time (i.e., less than half of the allocated time used) they
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were advised to attenuate their conﬁdence and to take more
time if not fully conﬁdent for the remaining trials. The aim of
this metacognition-augmented CR condition was to sensitize
participants to the disadvantages of high-conﬁdent and hasty
decision-making suggesting that “gut feelings” may be faulty. We
hypothesized that the conventional CR condition may improve
subjective and perhaps even objective cognitive impairment.
The metacognition-enhanced CR condition was hypothesized
to additionally improve the jumping to conclusions bias and
to attenuate response conﬁdence (as measured by a memory
task).
Materials and Methods
Participants
The present study was approved by the ethics committee of
the German Society for Psychology (DGPs). Participants were
recruited from various sources. A total of 223 former patients
of the Department of Psychiatry and Psychotherapy, University
Medical Center Hamburg-Eppendorf (Germany) with veriﬁed
diagnostic status (schizophrenia or schizoaﬀective disorder)
were informed about the study via email. All participants
had given explicit permission to be contacted for future
studies. Furthermore, 309 emails were sent to clinicians asking
them to pass on information about the study to patients
meeting inclusion criteria. Finally, upon the approval of
webmasters study invitations were posted in several guided
self-help internet networks pertaining to schizophrenia and
psychosis (these websites provided reliable information on the
disorder and fostered the exchange of individuals aﬀected with
psychosis).
The following inclusion criteria were applied: age between 18
and 65 years, willingness to provide electronic informed consent
and to participate in anonymous (internet-based) surveys as well
as a diagnosis of schizophrenia or schizoaﬀective psychosis.
All posts and emails contained a weblink directing interested
parties to the baseline survey. The trial was created using
Questback
R© which does not store IP addresses. Group allocation
was carried out at random.
The ﬁrst page of the online survey essentially repeated
the information of the email (random assignment to either
themybraintraining standard version, metacognition-augmented
mybraintraining, or waitlist control group; inclusion criteria) in
everyday language. It was announced that all participants would
receive free access to the online program (mybraintraining) for
1 year, either immediately or after a 6-week delay. Moreover,
all completers would receive a manual containing mindfulness
exercises at the end of the study.
Multiple log-ins via the same computer were prevented
by means of “cookies.” The survey consisted of the following
parts: invitation, informed consent (mandatory), optional
consent to contact the patient’s clinician in order to verify
diagnostic status (to do this, participants had to provide
their own name as well as the name and address of the
clinician), demographic section (e.g., gender, age), medical
information (e.g., medication, psychiatric diagnoses), assessment
of psychopathology I (see questionnaire section below),
encoding memory phase, assessment of psychopathology II
(see questionnaire section below), memory recognition test,
ﬁsh task (jumping to conclusions), and request for an email
address (to match baseline and post survey data). Then, we
asked participants to endorse whether or not they had responded
honestly. Finally, participants were given the opportunity to
leave comments.
No monetary compensation was oﬀered for participation.
Individuals who were randomly assigned to the waitlist condition
were informed that they would receive access after completing the
follow-up survey 6 weeks later.
Participants in two experimental groups were given access
to one of two versions of mybraintraining within 24 h.
This email also contained information about the rationale of
mybraintraining or metacognition-augmented mybraintraining.
Participants in the experimental groups received weekly email
reminders encouraging them to use the program on a regular
basis.
Procedure
Six weeks after the baseline assessments, participants were invited
via email to participate in the post survey. Up to two reminders
were dispatched in case subjects failed to complete the post
assessment. Three months after the post assessment, invitations
for a follow-up assessment were sent. Again, up to two reminders
were dispatched if subjects did not ﬁll out the ﬁnal assessment.
Post Assessment
For the post survey, individuals were requested to enter their
email address to allow matching post data with baseline
data. The post assessment consisted of the following parts:
introduction, current treatment and medication, assessment
of psychopathology I, encoding memory phase, assessment of
psychopathology II, memory recognition test, ﬁsh test (jumping
to conclusions), and evaluation of the online training (see
below). Similar to the baseline assessment, we asked participants
whether or not they had responded honestly and gave them the
opportunity to leave comments.
Subsequent to completion of the post assessment, all
participants received a manual on relaxation and mindfulness
exercises. Participants in the waitlist condition also received
access to the standard CR condition. Patients in the standard
mybraintraining condition did not receive the metacognition-
augmented CR training and vice versa.
Follow-Up Assessment
Three months after the post assessment, participants were
invited to a follow-up assessment. This ﬁnal assessment was
not part of our initial study design. As participants in the
waitlist group received access to the mybraintraining standard
version subsequent to completion of the post assessment,
this ﬁnal follow-up assessment did not allow comparison of
the three groups. Hence, the follow-up analysis compared
the standard CR group (immediate or delayed) with the
metacognition-augmented CR group. As an incentive for
continued participation, individuals received a manual with
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exercises derived from “Acceptance and Commitment Therapy.”
The follow-up assessment was a shorter version of the post
assessment and involved a selection of previously used scales (see
below). As the follow-up was not announced from the start, we
expected a higher non-completion rate.
Questionnaires (Online Assessment)
Participants were asked to complete the following questionnaires
(the survey proceeded only after all items had been answered):
Paranoia Checklist (Freeman et al., 2005)
The Paranoia Checklist is an 18 item questionnaire assessing
paranoid beliefs and suspiciousness. The psychometric properties
are good (Freeman et al., 2005; Lincoln et al., 2010a,b). In our
slightly adapted version, participants are asked to rate their
present symptom severity on a ﬁve-point Likert scale ranging
from 1 (not at all) to 5 (extremely).
Center for Epidemiologic Studies-Depression Scale
(CES-D)
The Center for Epidemiologic Studies-Depression Scale (CES-
D) is a 20 item questionnaire covering depressive symptoms;
the reliability and validity of the CES-D have been established
previously (Radloﬀ, 1977; Hautzinger and Brähler, 1993). In
the present study, CES-D items were presented intermixed with
items from the Paranoia Checklist.
Launay-Slade Hallucination Scale-Revised (LSHS-R;
Bentall and Slade, 1985)
The Launay-Slade Hallucination Scale-Revised (LSHS-R) is a 16
item questionnaire covering sleep-related hallucinations, vivid
daydreams, intrusive thoughts, and auditory hallucinations. Its
reliability has been demonstrated elsewhere (Goodarzi, 2009).
Psychosis patients with hallucinations usually score higher than
remitted patients, and the latter in turn reach higher scores
than patients who never experienced hallucinations (Varese
et al., 2012). The LSHS-R was not included in the follow-up
assessment.
Beck Cognitive Insight Scale (BCIS) – Extended
The Beck Cognitive Insight Scale (BCIS; Beck et al., 2004)
is a 15-item scale that measures the degree of patients’
self-reﬂectiveness and overconﬁdence in the interpretation of
experiences. Principal component analysis (Beck et al., 2004)
suggests a two-dimensional structure (self-reﬂectiveness and self-
certainty). According to the original article (Beck et al., 2004), the
BCIS demonstrates good convergent, discriminant, and construct
validity. The psychometric properties of the German translation
used in the present study are good as well (Mass et al., 2012).
We complemented the BCIS with a number of self-developed
novel items asking for subjective cognitive deﬁcits (e.g., “I have
trouble learning new things”). The BCIS was not administered in
the follow-up assessment.
Jumping to Conclusions
We administered an online version of the probabilistic reasoning
task (Speechley et al., 2010; Moritz et al., 2012a), which slightly
FIGURE 1 | Example for an exercise from category “Logic.” The
participant had to identify the young of the parent animals (the upper left
response option is correct). In the standard version, the participant had to
indicate his or her choice and was then informed about the outcome (correct
versus incorrect). In the metacognitive-augmented condition, the participant
was asked after each response whether he or she was certain that the
response was correct. In case of a very fast incorrect response (less than half
of the allotted time indicated by the time bar; see bar left to clock symbol) or a
high-confident incorrect response, patients were encouraged by automatic
feedback to either take more time before completing an item and/or to
attenuate response confidence if the available evidence was insufficient.
diﬀers from the original beads task as it employs a diﬀerent
scenario (lakes with ﬁsh instead of jars with beads). Three parallel
versions were set up to avoid practice eﬀects. In each version,
two lakes with colored ﬁsh in opposing likelihood (e.g., 80%
orange vs. 20% gray ﬁsh, and vice versa) were presented to
the participant. Following each “catch,” participants were asked
to make two judgments: (1) a probability judgment about the
likelihood that the ﬁsh was/were being caught from lake A versus
lake B, and (2) whether the available amount of information
would justify a decision or not. The instruction emphasized that
the ﬁshermanwould not change the lake throughout the task. The
ratio of ﬁsh in each lake was shown at the bottom of each slide
along with previously caught ﬁsh (the last catch was indicated
with an arrow). In total, 10 ﬁsh were presented; one lake was
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TABLE 1 | Baseline characteristics of the full sample. Means, SD, (in brackets) and frequency.
Variable Waitlist Standard cognitive
remediation
Metacognition-augmented
cognitive remediation
Statistics
(n = 30) (n = 30) (n = 30)
Background variables
Age in years 37.03 (12.66) 40.10 (9.29) 40.80 (9.97) F (2;89) = 1.04, p = 0.356
Sex (male/female) 10/20 11/19 12/18 χ2 = 0.29, p = 0.866
Parallel treatments
Antipsychotics (yes/no) 27/3 25/5 26/4 χ2 = 0.58, p = 0.749
Inpatient treatment (yes/no) 1/29 2/28 1/29 χ2 = 0.52, p = 0.770
Outpatient treatment (yes/no) 20/10 17/13 17/13 χ2 = 0.83, p = 0.659
Psychotherapy (yes/no) 8/22 7/23 7/23 χ2 = 0.12, p = 0.942
Waiting for psychotherapy (yes/no) 1/29 2/28 1/29 χ2 = 0.52, p = 0.770
Reasoning
Jumping to conclusions (decision
after first or second fish)
40% 47% 40% χ2 = 0.36, p = 0.833
Memory test
Hits 13.23 (2.31) 13.50 (2.05) 13.52 (1.23) F (2;89) = 0.74, p = 0.483
False alarms 1.00 (1.76) 0.93 (1.46) 0.77 (1.14) F (2;89) = 0.20, p = 0.820
High-confident responses 25.97 (5.69) 25.00 (5.41) 26.83 (3.56) F (2;89) = 1.02, p = 0.365
Beck Cognitive Insight Scale (extended)
Self-reflectiveness 9.13 (3.16) 8.90 (2.88) 10.10 (3.08) F (2;89) = 1.31, p = 0.274
Self-certainty 7.53 (2.61) 6.77 (2.53) 6.70 (2.31) F (2;89) = 1.04, p = 0.357
Subjective cognitive dysfunction 9.20 (3.80) 8.40 (4.06) 9.00 (4.19) F (2;89) = 0.32, p = 0.726
strongly suggested by the chain of events (D–D–D–N–D–D–D–
D–N–D; D= dominant color of ﬁsh; N= non-dominant color of
ﬁsh). Jumping to conclusions was deﬁned as a decision after one
or two ﬁsh. We also computed the number of draws to decisions.
Memory Test
Three parallel versions of a newly developedmemory recognition
test were composed. The test was modeled after the Auditory
Verbal Learning Memory Test (AVLT) but did not encompass
active recall. In the (incidental) encoding phase (i.e., unlike in the
AVLT participants were not instructed that their later task would
be to memorize the items), participants were presented 15 nouns
[each ﬁve words that were pre-classiﬁed by the authors as positive
(e.g., cake), negative (e.g., accident) or neutral (e.g., table)]
and requested to appraise each noun as either positive, neutral
or negative (valence). Later, participants were presented the
previously presented 15 words intermingled with 15 distractor
words of diﬀerent valence in random order (recognition phase).
Participants were asked to rate if the respective word had been
presented before (i.e., in the valence task) and how conﬁdent
they were in the correctness of their judgment. Items had to be
endorsed on a four-point Likert scale (1 = old word, certain;
2= old word, uncertain; 3= newword, uncertain; 4= newword,
certain). There was an equal number (n = 15) of (pre-deﬁned)
negative, positive, and neutral words, both with respect to old
(studied) and new (distractor) words.
Mybraintraining Professional
Mybraintraining is a CR program which is available online
(no local installation on PC necessary) at http://www.
mybraintraining.com/. The program can be used both as a
self-help or conventional treatment device (i.e., guided treatment
by neuropsychologist or occupational therapist). The program
encompasses 30 exercises aimed at stimulating executive
functioning. Exercises fall into four broad categories: calculation,
logic, memory, and vision. The exercises were designed during
development of the “Train your Brain with Dr. Kawashima”
program in cooperation with the Industry University Research
Project with Professor Dr. Ryu¯ta Kawashima. According to
the developers (personal communication), performance of
each exercise had to be accompanied by activation of the
frontal lobe (presented in the “Scientiﬁc Details” part of each
exercise).
The diﬃculty of the sessions automatically adapts to the
patients’ performance. mybraintraining includes motivating
elements as used commonly in video games in order to increase
fun and adherence. The administrator can deﬁne individual
training plans and adapt exercises to each patient’s needs (e.g.,
level of diﬃculty, varied time limits, etc.). This tool also compiles
statistics (e.g., to compare one patient with reference group,
number of sessions completed, training success). Data protection
and security comply with industry standards.
For the present study, we used the “daily test” tool of
mybraintraining Professional which encourages patients to
perform a random string of four exercises, one from each
category (calculation, logic, memory, and vision).
In addition to the conventional version of mybraintraining
Professional, a condition termed metacognitive-augmented
CR condition was constructed, which aimed to reduce
overconﬁdence and jumping to conclusions. This version
asked participants to make a conﬁdence judgment (certain versus
uncertain) after each trial. The program then provided feedback
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TABLE 2 | Differences among conditions across time (sample with available pre–post scores).
Variable Waitlist (n = 29) Standard cognitive
remediation (n = 20)
Metacognition-augmented
cognitive remediation (n = 20)
ANOVA (G = group effect, T = time,
I = interaction) [for JTC generalized
linear equations were applied]
pre post pre post pre post
Draws to
decision
3.72 (2.34) 4.55 3.27) 3.32 (2.36) 2.84 (1.77) 3.20 (2.14) 3.70 (2.27) G: F (2;65) = 1.31, p = 0.277, η2p = 0.04
T: F (1;65) = 1.64, p = 0.204, η2p = 0.02
I: F (2;65) = 3.09, p = 0.052, η2p = 0.09
JTC (decision
after 1st or 2nd
fish = 1)
0.38 (0.49) 0.31 (0.47) 0.47 (0.51) 0.53 (0.51) 0.40 (0.50) 0.40 (0.50) G: Wald χ2 (1) = 0.48, p = 0.827
T: Wald χ2 (1) = 0.00, p = 0.980
I: Wald χ2 (1) = 0.78, p = 0.378
Beck Cognitive Insight Scale – extended
Self-
reflectiveness
8.97 (3.08) 8.72 (2.85) 8.85 (2.30) 9.95 (2.76) 9.70 (3.20) 9.10 (3.91) G: F (2;66) = 0.37, p = 0.694, η2p = 0.01
T: F (1;66) = 0.06, p = 0.813, η2p = 0.00
I: F (2;66) = 1.87, p = 0.162, η2p = 0.05
Self-certainty 7.72 (2.43) 6.34 (1.91) 7.05 (2.28) 6.85 (2.66) 6.90 (2.31) 6.75 (2.17) G: F (2;66) = 0.06, p = 0.943, η2p = 0.00
T: F (1;66) = 6.84, p = 0.013, η2p = 0.09
I: F (2;66) = 3.56, p = 0.034, η2p = 0.10
Subjective
cognitive
dysfunctions
9.45 (3.61) 9.76 (3.47) 8.35 (3.51) 8.35 (4.22) 8.90 (4.04) 9.20 (4.37) G: F (2;66) = 0.71, p = 0.459, η2p = 0.02
T: F (1;66) = 0.42, p = 0.520, η2p = 0.01
I: F (2;66) = 0.10, p = 0.904, η2p = 0.00
Memory test
Hits 13.21 (2.35) 13.00 (2.41) 13.63 (2.09) 12.47 (1.65) 14.00 (1.12) 13.05 (1.23) G: F (2;65) = 0.58, p = 0.563, η2p = 0.02
T: F (1;65) = 6.86, p = 0.011, η2p = 0.09
I: F (2;65) = 1.08, p = 0.346, η2p = 0.03
False memories 1.00 (1.79) 1.38 (2.08) 0.73 (1.24) 1.32 (1.86) 0.45 (0.60) 1.85 (2.81) G: F (2;65) = 0.60, p = 0.942, η2p < 0.01
T: F (1;65) = 11.55, p = 0.001, η2p = 0.15
I: F (2;65) = 1.85, p = 0.166, η2p = 0.05
All
high-confident
responses
25.93 (5.79) 24.34 (6.94) 24.42 (5.91) 22.42 (5.62) 27.65 (3.38) 23.50 (6.21) G: F (2;65) = 1.05, p = 0.356, η2p = 0.03
T: F (1;65) = 11.34, p = 0.001, η2p = 0.15
I: F (2;65) = 1.08, p = 0.345, η2p = 0.03
Psychopathology
LSHS-R 29.39 (8.37) 29.00 (8.51) 28.85 (9.45) 28.40 (9.99) 28.00 (10.43) 29.25 (11.77) G: F (2;65) = 0.03, p = 0.971, η2p = 0.00
T: F (1;65) = 0.09, p = 0.765, η2p = 0.00
I: F (2;65) = 1.44, p = 0.243, η2p = 0.04
Paranoia
Checklist
40.03 (17.88) 37.55 (16.86) 38.00 (16.67) 32.85 (13.79) 31.35 (17.23) 30.60 (16.59) G: F (2;66) = 1.37, p = 0.261, η2p = 0.04
T: F (1;66) = 8.33, p = 0.005, η2p = 0.11
I: F (2;66) = 1.62, p = 0.205, η2p = 0.05
CES-D 55.07 (14.49) 50.66 (14.32) 56.75 (13.49) 52.40 (16.30) 47.75 (15.98) 47.15 (15.75) G: F (2;66) = 1.42, p = 0.250, η2p = 0.04
T: F (1;66) = 6.40, p = 0.014, η2p = 0.09
I: F (2;66) = 1.00, p = 0.373, η2p = 0.03
CES-D, Center for Epidemiologic Studies-Depression Scale; LSHS-R, Launay-Slade Hallucination Scale-Revised; G, main effect of group, T, main effect of time, I,
interaction effect of group and time.
in case of hasty and/or high-conﬁdent errors (see Figure 1).
Since the termination of the study, this additional option is now
part of the standard program.
Strategy of Data Analysis
Simple cross-sectional analyses were performed using t-tests
for metric (e.g., age) and cross table statistics for nominal
data (e.g., gender distribution). For group comparisons over
time we used mixed ANOVAs with Group as the between-
subject factor and Time as the within-subject factor when
using metric data. In case of binary data (e.g., rate of jumping
to conclusions) a generalized estimating equations procedure
was performed which was deemed more appropriate than a
conventional repeated-measures ANOVA.
Results
Table 1 shows the baseline characteristics of the sample, of which
76 patients could be reached for the post assessment and 38
for the follow-up. No signiﬁcant diﬀerences emerged for any
demographic, psychopathological, or cognitive variable.
Across time, medication status did not change between groups
(p > 0.3). At baseline, 87% of the participants were medicated
with antipsychotics, at post (85%) and follow-up (87%) the
rate was almost identical. Likewise, treatment status [yes (i.e.,
outpatient, inpatient, day clinic, practitioner) versus no] did not
change between groups across time (p> 0.5). Most patients were
treated as outpatients (pre: 60%, post: 57.5%, follow-up: 53.3%).
Rates did not diﬀer among groups at any point in time (p> 0.6).
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FIGURE 2 | Patients who underwent the metacognition-augmented
cognitive remediation program (MC-MBT) showed less jumping to
conclusions from baseline to follow-up (upper) and delayed
decision-making (lower) relative to participants who received the
standard version (MBT; immediately or delayed), respectively.
Pre versus Post
Table 2 shows between-group diﬀerences from pre to post for the
per protocol sample (i.e., participants in the CR conditions had
logged into mybraintraining at least once). Groups did not diﬀer
signiﬁcantly on any symptoms, and cognition measures.
Pre versus Follow-Up
At follow-up, 38 individuals underwent another assessment
[metacognition-augmented mybraintraining: n = 14; standard
mybraintraining (immediate or delayed): n = 24]. For draws
to decision, the eﬀect of time achieved statistical trend level,
F(1;36) = 3.46, p = 0.071, η2p = 0.09, while the group eﬀect was
insigniﬁcant, F(1;36) = 2.44, p = 0.127, η2p = 0.06. This was
qualiﬁed by a signiﬁcant interaction, F(1;36) = 5.82, p = 0.021,
η2p = 0.14; Figure 2 shows that participants in the metacognition-
augmented condition showed delayed decision-making while
participants in the standard condition showed a tendency
toward more jumping to conclusions. Likewise, using generalized
estimating equations to ﬁt a repeated-measures logistic regression
to jumping to conclusions data (decision after ﬁsh 1 or 2),
a signiﬁcant interaction occurred favoring the metacognition-
augmented condition, Wald χ2(1) = 4.55, p = 0.033.
For the number of high-conﬁdent responses on the memory
test the eﬀect of time, F(1;36) = 5.12, p = 0.030, η2p = 0.125
but not group, F(1;36) = 0.11, p = 0.737, η2p < 0.01 were
signiﬁcant, which was qualiﬁed by signiﬁcant interaction at an
almost large eﬀect size, F(1;36) = 5.59, p = 0.024, η2p = 0.13. As
can be seen in Figure 3 the number of high-conﬁdent responses
remained stable in the standard CR group but declined in the
metacognition-augmented group.
No signiﬁcant interaction emerged for depression,
F(1;36) = 0.14, p = 0.91, η2p < 0.01, paranoia, F(1;36) = 0.64,
p = 0.428, η2p = 0.02, hits, F(1;36) = 0.78, p = 0.785, η2p < 0.01,
and false memories, F(1;36) = 1.23, p = 0.276, η2p = 0.03.
Retrospective Assessment (Post)
Feasibility and comprehensibility of the training were rated high
by respondents and did not diﬀer between the two CR conditions
(Table 3). Patients were able to perform the tasks alone and
rated the exercises as helpful, although only a minority reported
symptom improvement.
Correlations between Performance and
Adherence with Symptomatology
We examined whether adherence and progress on the CR
program impacted outcome variables. Progress in performance
in CR memory exercises (slope change measure) was correlated
at r = 0.61 (p = 0.026) with improvement in the memory
test from pre to post for the standard mybraintraining
group (no other variables turned signiﬁcant). Gain in overall
performance (all exercises combined) in the metacognition-
FIGURE 3 | Patients in the metacognition-augmented cognitive
remediation condition (MC-MBT) attenuated confidence ratings from
baseline to the follow-up period relative to the standard CR group
(MBT).
Frontiers in Psychology | www.frontiersin.org 7 August 2015 | Volume 6 | Article 1048
Moritz et al. Metacognition-augmented cognitive remediation training
TABLE 3 | Retrospective subjective assessment (“fully applies” and “rather applies” were combined) at post.
Variable Standard cognitive
remediation
Metacognition-augmented
cognitive remediation
Statistics
(n = 20) (n = 20)
Program is suitable for self-administration. 95% 100% χ2 = 1.13, p = 0.567
The instructions of the program were
understandable.
85% 85% χ2 = 1.90, p = 0.911
I considered the exercises as helpful. 65% 70% χ2 = 0.70, p = 0.704
I was able to regularly perform the exercises in
the past weeks.
60% 70% χ2 = 1.18, p = 0.554
I had to force myself to perform the program
regularly.
25% 45% χ2 = 2.05, p = 0.359
The extent of the training was just right. 75% 60% χ2 = 1.33, p = 0.515
Other persons have helped me with the
program.
10% 0% χ2 = 10.06, p < 0.001
I think the training is more appropriate in the
framework of a psychotherapy.
35% 15% χ2 = 4.51, p = 0.105
I could integrate the lessons learnt into my daily
routine.
45% 20% χ2 = 4.30, p = 0.116
Symptoms have decreased due to the
program.
30% 20% χ2 = 3.28, p = 0.149
augmented mybraintraining condition correlated with more
draws to decision in the ﬁsh task, r = 0.54, p = 0.021 and less
jumping to conclusions at trend level, r = −0.42, p = 0.079.
Similarly, the number of exercises performed (objective measure)
in the metacognition-augmented mybraintraining condition
correlated with less jumping to conclusions signiﬁcantly
(r = −0.398, p = 0.040) and less draws to decision over
time at trend level (r = 0.353, p = 0.071). Adherence in
the standard condition (number of days the CR program
was used) was associated with reduction of depression over
time (r = 0.467, p = 0.028). Likewise, number of exercises
performed (objective) was correlated with decline of depressive
symptoms (r = 0.482, p = 0.023), again for the standard version
only.
Test–Retest Reliability of the Data and
Plausibility Checks
Test–retest reliability was determined for pre–post scores only
due to the low number of participants at follow-up. Consistency
of the psychopathological scales was excellent (CES-D: pre–post:
r = 0.817, p < 0.001; Paranoia Checklist: r = 0.891, p < 0.001,
LSHS-R: r = 0.936, p < 0.001). The recognition test showed low
reliability from pre to post (r = 0.255, p= 0.024). The correlation
between subjective adherence (number of days exercises were
performed: 0–7 days/week) and objective number of exercises
performed (data extracted from log ﬁles) was good (r = 0.817,
p< 0.001).
Discussion
The study set out to examine the eﬀectiveness of conventional
as well as metacognition-augmented CR training. Most patients
were on antipsychotic medication and in outpatient treatment.
Treatment status did not change substantially across time. Special
precautions were taken to verify diagnostic status. Speaking
for the quality of the data, the test-retest reliability of the
questionnaires was very high. Further, subjective and objective
adherence were highly correlated.
We used a low-threshold online CR training termed
mybraintraining targeting four cognitive domains which
according to the developers (personal communication,
unpublished data) are linked with metabolic changes in frontal
lobe areas. Patients carried out the exercises on their home
computer. The program was delivered unguided; no individual
adaption was performed apart from automatic adjustments
pertaining to diﬃculty. Our hypotheses were partly conﬁrmed.
Group comparisons indicate that conventional CR did not
impact any outcome measure suggesting that cold cognitive
functioning is quite resistant to cognitive training interventions,
at least in a rather chronic and subacute psychosis population.
At the same time, the CR version showed some interesting
correlations with depression: the number of completed sessions
was correlated with a reduction on the CES-D which could hint
at (but is no proof for) the possibility that training improves well-
being. This would be a potentially important ﬁnding as neither
antipsychotic (Leucht et al., 2009) nor antidepressant medication
(Kishi and Iwata, 2014) exert substantial eﬀects on depression
in psychosis. Likewise, psychotherapy with cognitive-behavioral
therapy only yields a small-to-medium eﬀect according to
a meta-analysis (Wykes et al., 2008). However, an opposite
causal relationship cannot be fully dismissed: Improvement of
well-being may enhance ﬁdelity to perform the tasks. Further,
performance gains on the memory task were correlated with
improvements on the objective memory test, speaking for the
ecological validity of the task. Again, however, group diﬀerences
were not signiﬁcant.
At follow-up, the metacognition-enhanced CR training
yielded the expected signiﬁcant eﬀects on the JTC bias (i.e.,
delayed decision-making) and reduced overconﬁdence. These
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ﬁndings are noteworthy since both biases are implicated in the
formation of psychosis and JTC is rather resistant to change (Ross
et al., 2011; So et al., 2012a,b). This delayed eﬀect is interesting
and may indicate that the newly acquired skills need some time to
settle before they become manifest. At post, we found substantial
correlations between ﬁsh task parameters with adherence and
performance gain.
At ﬁrst sight, the results are sobering in face of recent reviews
indicating that CR tasks may yield at least small-to-medium
eﬀects on objective neurocognitive functioning (McGurk et al.,
2007; Wykes et al., 2011). A number of factors may have
prevented the hypothesized pattern of results from emerging.
First, the training was self-paced, that is, individuals were
encouraged to perform the tests daily but in fact many did
not perform the tasks on a regular basis. In contrast, in
many clinical trials on CR there are frequent appointments
and homework is checked by therapists. A certain (cued)
participation frequency may be necessary to show an eﬀect. Our
weekly email reminders may not have been suﬃciently strong
cues. Second, the group was not severely ill (mainly outpatient
treatment) and self-help was performed predominantly at home
as patients were not hospitalized. A chronic and more remitted
sample is likely to show less beneﬁt from training than an
acute and hospitalized sample (e.g., because of regression
to the mean). Thus, a ﬁrst-episode and CR-naive treatment
group may show better outcome. Third, the outcome measures
did not cover the full range of domains targeted. In fact,
we had only one objective memory test with rather low
reliability. Perhaps the training exerted eﬀects on functions
not covered by our battery. Future studies should therefore
administer a wider range of behavioral tests. Finally, while the
initial sample was rather large and we had a good retention
rate for the post phase, less than 50% participated in the
follow-up.
Conclusion
The metacognition-enhanced CR condition showed delayed
changes on two prominent cognitive biases which are implicated
in the pathogenesis of positive symptoms: jumping to conclusions
and overconﬁdence. The program under investigation now
incorporates these additional metacognitive features which are
deemed important as prior studies suggest that JTC is quite
resistant to change (see above) and is not only tied to positive
symptoms but predicts functional outcome to some degree
(Andreou et al., 2014). It seems that the training – like
metacognitive training (MCT; Moritz et al., 2014a) – successfully
“sows the seeds of doubt.” Further studies should investigate
whether this leads to a reduction of symptoms in the long run.
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